S Rahbar
Overview
Explore the profile of S Rahbar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
414
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Allahverdy A, Rahbar S, Mirzaei H, Ajami M, Namdar A, Habibi S, et al.
J Biomed Phys Eng
. 2021 Feb;
11(1):61-72.
PMID: 33564641
Background: There are many studies to investigate the effects of each interacting component of tumor-immune system interactions. In all these studies, the distinct effect of each component was investigated. As...
2.
Rahbar S, Novin M, Alizadeh E, Shahnazi V, Pashaei-Asl F, AsrBadr Y, et al.
Cell Mol Biol (Noisy-le-grand)
. 2017 Sep;
63(8):77-83.
PMID: 28886318
Spermatogenesis is proliferation and differentiation processes of stem spermatogonia into mature spermatozoa controlled by the genes responsible for transcription and post transcription levels. MicroRNAs (miRNA) are the key factors during...
3.
Satheesan S, Figarola J, Dabbs T, Rahbar S, Ermel R
Br J Pharmacol
. 2014 Mar;
171(12):3103-14.
PMID: 24611770
Background And Purpose: We determined the effects of treatment with LR-90, an inhibitor of advanced glycation end products, on the mechanical properties of the arterial system in streptozotocin (STZ)-induced diabetic...
4.
Figarola J, Loera S, Weng Y, Shanmugam N, Natarajan R, Rahbar S
Diabetologia
. 2008 Mar;
51(5):882-91.
PMID: 18317729
Aims/hypothesis: Previous studies have shown that LR-90, a new inhibitor of AGE formation, prevented the development of experimental type 1 diabetic nephropathy. In this study, we examined the effects of...
5.
Bhatwadekar A, Glenn J, Figarola J, Scott S, Gardiner T, Rahbar S, et al.
Br J Ophthalmol
. 2008 Jan;
92(4):545-7.
PMID: 18211931
Background: Diabetic retinopathy is associated with accumulation of advanced glycation end products in the retinal microvasculature. LR-90 is an effective multistage inhibitor of advanced glycation with renoprotective and anti-inflammatory properties....
6.
Figarola J, Scott S, Loera S, Tessler C, Chu P, WEISS L, et al.
Diabetologia
. 2003 Jul;
46(8):1140-52.
PMID: 12845431
Aims/hypothesis: Advanced glycation and lipoxidation endproducts have been implicated in the pathogenesis of diabetic complications, including diabetic nephropathy. LR-90, a new advanced glycation endproduct inhibitor, was investigated for its effects...
7.
Ali J, Rahbar S, Burjaq H, Sultan A, Al Flamerzi M, Shahata M
J Assist Reprod Genet
. 2003 Jun;
20(5):177-81.
PMID: 12812460
Purpose: To elucidate the appropriateness of current indications for assisted hatching (AH) in cleavage stage human embryos and to confirm our preliminary findings that only young patients (about 67%) benefit...
8.
Lauffer J, Tang L, Zhang T, Hinoue T, Rahbar S, Odo M, et al.
Regul Pept
. 2001 Dec;
102(2-3):157-64.
PMID: 11730988
Background And Aim: Pituitary adenylate-cyclase activating peptide (PACAP) is a more potent proliferative agent than gastrin for rat enterochromaffin-like (ECL) cell proliferation in vitro. The role of this neurotransmitter during...
9.
Rahbar S, Yerneni K, Scott S, Gonzales N, Lalezari I
Mol Cell Biol Res Commun
. 2000 Oct;
3(6):360-6.
PMID: 11032758
Enhanced formation and accumulation of advanced glycation endproducts (AGEs), have been implicated as a major pathogenesis process leading to diabetic complications, normal aging, atherosclerosis, and Alzheimer's Disease. Several potential drug...
10.
Rahbar S, Natarajan R, Yerneni K, Scott S, Gonzales N, Nadler J
Clin Chim Acta
. 2000 Oct;
301(1-2):65-77.
PMID: 11020463
Enhanced formation and accumulation of advanced glycation end products (AGEs) have been proposed to play a major role in the pathogenesis of diabetic complications, and atherosclerosis, leading to the development...